BioSpace News Archive

TELA Bio, Inc. today announced it has entered into a distribution agreement with Next Science granting TELA exclusive rights to sell and market Next Science’s proprietary antimicrobial surgical wash with XBIO ® technology.

Apellis Pharmaceuticals today announced that the company will host a conference call and webcast to discuss its third quarter 2021 financial results on Monday, November 8, 2021 at 4:30 p.m. ET.

The United States Food and Drug Administration (FDA) has granted a meeting with Novatek to consider Emergency Use Authorization (EUA) of TQ Formula to treat non-hospitalized COVID-19 patients

NuVasive, Inc. announced today that management will virtually present at the Credit Suisse 30th Annual Healthcare Conference on Thursday, November 11, 2021 at 8:20 a.m. PT

Theseus Pharmaceuticals, Inc. today announced U.S. Food and Drug Administration (FDA) clearance of an investigational new drug (IND) application to evaluate THE-630

Bausch + Lomb announced that seven scientific posters involving the company’s products, as well as data from the company’s Antibiotic Resistance Monitoring in Ocular MicRoorganisms surveillance study, will be presented during the annual meetings of the American Academy of Optometry in Boston and American Academy of Ophthalmology in New Orleans.

Rivus Pharmaceuticals Inc. today announced positive results from both single and multiple ascending dose portions of its Phase 1 clinical trial of HU6. HU6, a first-in-class, orally administered Controlled Metabolic Accelerator (CMA) therapy

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced the presentation of preclinical data from a series of internally developed dual agonists of the glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors at ObesityWeek® 2021.

AstraZeneca is proud to announce contributions to 30 nonprofit, community-based organizations nationwide through the ACT on Health Equity: Community Solutions Challenge.

908 Devices Inc. announced at the American Society for Mass Spectrometry (ASMS) conference today a new Oligos assay kit for its ZipChip device that enables fast and accurate identification and quantitation of oligonucleotides.